SOHONOS palovarotene 2.5 mg capsule blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

palovarotene, Quantity: 2.5 mg

Verfügbar ab:

Ipsen Pty Ltd

Darreichungsform:

Capsule, hard

Zusammensetzung:

Excipient Ingredients: croscarmellose sodium; lactose monohydrate; povidone; magnesium stearate; microcrystalline cellulose; sodium lauryl sulfate; titanium dioxide; potable water; Gelatin; propylene glycol; butan-1-ol; purified water; isopropyl alcohol; Shellac; ethanol absolute; iron oxide black; ammonia; potassium hydroxide

Verabreichungsweg:

Oral

Einheiten im Paket:

28 hard capsules

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

SOHONOS is indicated to reduce the formation of heterotopic ossification in adults and children aged 8 years and above for females and 10 years and above for males with fibrodysplasia ossificans progressiva (FOP).

Produktbesonderheiten:

Visual Identification: Size 0 hard gelatin capsules with opaque white body and cap, imprinted with "PVO 2.5" on each side of the capsule body in black ink; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Registered